Isocitrate Dehydrogenase 2 Inhibitor [EPC]

612 reported adverse events

Drugs of this class: VORASIDENIB

These side effects are most commonly reported by patients taking drugs of the Isocitrate Dehydrogenase 2 Inhibitor [EPC] class:

# Side effect Count
0 ALANINE AMINOTRANSFERASE INCREASED 83
1 ASPARTATE AMINOTRANSFERASE INCREASED 68
2 FATIGUE 67
3 MALIGNANT NEOPLASM PROGRESSION 46
4 SEIZURE 41
5 HEADACHE 39
6 NAUSEA 38
7 HEPATIC CYTOLYSIS 34
8 HEPATIC ENZYME INCREASED 34
9 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28
See all common reactions for Isocitrate Dehydrogenase 2 Inhibitor [EPC]

Drugs of the Isocitrate Dehydrogenase 2 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERITONEOVENOUS SHUNT 1 0.2000
1 PLATELETCRIT INCREASED 2 0.1176
2 INCISION SITE DISCOMFORT 1 0.0714
3 CREATINE KINASE DECREASED 1 0.0435
4 FIRST TRIMESTER PREGNANCY 1 0.0400
5 INCREASED LIVER STIFFNESS 1 0.0294
6 DEPRESSION POSTOPERATIVE 1 0.0233
7 PLATELET DISTRIBUTION WIDTH DECREASED 1 0.0213
8 MISCARRIAGE OF PARTNER 1 0.0182
9 BLOOD LACTIC ACID ABNORMAL 2 0.0179
See all enriched reactions for Isocitrate Dehydrogenase 2 Inhibitor [EPC]